
Esokal 40mg Injection
Marketer
Kalmia Healthcare
Salt Composition
Esomeprazole (40mg)
Overview Esokal 40mg Injection
Acid-reducing injection, Esokal 40mg, lowers stomach acid production. It treats stomach and intestinal acid-related disorders, including acid reflux and other conditions stemming from excessive acid. Esokal 40mg is also prophylactic against stress ulcers in critically ill patients and is given pre-anesthesia to minimize aspiration risks. A proton pump inhibitor (PPI), it's intravenously administered by medical professionals only when deemed preferable to oral medication. Dosage and treatment length are determined by your physician based on your condition and response. Lifestyle modifications, such as smaller, more frequent meals and avoiding caffeine, spicy foods, and fatty foods, can enhance treatment. Common side effects – injection site reactions, nausea, headache, dizziness, gas, diarrhea, abdominal pain, and fundic gland polyps – are typically mild, but persistent or bothersome symptoms warrant medical attention. Discuss bone loss (osteoporosis) prevention, such as calcium and vitamin D supplementation, with your doctor. Esokal 40mg is contraindicated in individuals with severe liver disease, those taking HIV medications, those with a history of similar medication allergies, or existing osteoporosis. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption should be avoided due to its acid-stimulating effect and potential symptom exacerbation.
Uses of Esokal 40mg Injection
Managing gastroesophageal reflux disease (GERD)
Major Benefits of Esokal 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Esokal 40mg Injection:
- Injection site reaction
- Headache
- Dizziness
- Dryness in mouth
- Nausea
- Abdominal pain
- Constipation
- Flatulence
- Diarrhea
- Fundic gland polyps
How to use Esokal 40mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Esokal 40mg Injection works:
The injectable formulation of Esokal, 40mg, functions as a proton pump inhibitor, decreasing stomach acid production to alleviate heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Esokal 40mg Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Esokal 40mg Injection during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Esokal 40mg Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Esokal 40mg Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
The administration of Esokal 40mg Injection requires careful monitoring in individuals exhibiting severe renal impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alterations are unnecessary for patients with mild or moderate kidney dysfunction.
LiverCAUTION
For individuals with severely compromised liver function, the administration of a 40mg Esokal injection necessitates careful monitoring. Dosage modification of the 40mg Esokal Injection may be necessary. Physician consultation is advised. Dosage alteration is unnecessary for patients exhibiting mild to moderate hepatic impairment.
What if you forget to take Esokal 40mg Injection :
Should you forget a scheduled dose of Esokal 40mg Injection, seek medical advice.
Facts to Know About Esokal 40mg Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
| Behavioral Class | Gastric acid suppressants |
